๐ŸŽ Black Friday: up to 50% off of annual plans
Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China flag China ยท Delayed Price ยท Currency is CNY
8.02
-0.49 (-5.76%)
Nov 20, 2026, 3:04 PM CST

SHE:301060 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,2381,4481,7421,6744,1991,778
Revenue Growth
-18.78%-16.88%4.05%-60.13%136.14%43.62%
Gross Profit
297.28342.87332.53329.311,779672.9
Operating Income
73.8714.89-62.37-155.551,071294.15
Net Income
40.96-30.75-109.44-141.59617.32203.84
Earnings Per Share
0.11-0.08-0.27-0.351.540.58
EPS Growth
----166.52%84.64%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Sales of in Vitro Diagnostic Products
709.04944.771,021922.91819.2
Medical Diagnostic Services
738.24797.17646.763,259947.22
Unallocated Other Business
0.760.256.7217.511.91
Total
1,4481,7421,6744,1991,778

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
816.28759.5828.95861.2665.81772.89
Total Debt
99.89171.44274.29407.35244.5965.7
Net Cash (Debt)
716.39588.06554.66453.85421.22707.19
Net Cash Growth
32.64%6.02%22.21%7.75%-40.44%32.75%
Net Cash Per Share
1.841.531.371.121.052.01

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
340.88268.85216.31546.9984.17223.51
Capital Expenditures
-47.86-58.49-76.62-398.89-230.08-118.88
Free Cash Flow
293.02210.36139.7148.1-145.91104.63
Free Cash Flow Growth
-17.55%50.59%-5.68%---15.16%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
24.01%23.68%19.09%19.67%42.37%37.84%
Operating Margin
5.97%1.03%-3.58%-9.29%25.50%16.54%
Pretax Margin
7.08%0.73%-5.90%-9.15%21.54%17.88%
Profit Margin
3.31%-2.12%-6.28%-8.46%14.70%11.46%
FCF Margin
23.67%14.53%8.02%8.85%-3.48%5.88%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1800.1800.200-0.3000.300
Dividend Per Share Growth
-10.00%-10.00%--0%-
Dividend Yield
2.24%1.95%2.19%-1.53%0.86%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
76.08---12.7268.24
P/FCF Ratio
10.9117.5226.0135.94-132.95
PS Ratio
2.582.552.093.181.877.82